Physician
Kutugata, Jorge
Kutugata, Jorge was paid $2.86M by Medicaid between Feb 2018 and Dec 2024, across 52 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 34% of everything it billed.
33Billing provider infoKUTUGATA, JORGE
WESLACO, TX 78596
WESLACO, TX 78596
33aNPI1285748996assigned 08/18/2006
33bProvider typePediatrics Physician
28Total paid$2.86M
24GClaims126,675
24DCodes billed52
24AFirst – last monthFeb 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Texas
Rank by total paid#163 of 1,136
Median peer was paid$329K
This provider vs. median8.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 34 | $1K | |
| 2019 | 29 | $1K | |
| 2020 | 3,921 | $70K | |
| 2021 | 29,134 | $582K | |
| 2022 | 37,971 | $896K | |
| 2023 | 29,978 | $709K | |
| 2024incomplete | 25,608 | $604K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 34% | 28,283 | 20,720 | $976K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 9.2% | 6,907 | 5,519 | $263K |
| 87428 | 8.5% | 4,148 | 3,384 | $242K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 6.4% | 14,518 | 12,042 | $183K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 6.0% | 4,661 | 3,933 | $170K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 5.7% | 12,713 | 5,324 | $162K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.3% | 2,081 | 1,923 | $152K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.1% | 1,937 | 1,777 | $146K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 3.7% | 10,555 | 4,189 | $105K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.6% | 1,373 | 1,311 | $103K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.5% | 1,309 | 1,196 | $101K |
| S8301 | Infection control supplies, not otherwise specified | 2.4% | 10,173 | 8,071 | $69K |
40 more codes
| 87807 | 2.2% | 6,089 | $62K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.8% | 8,788 | $53K |
| 99203 | Doctor's office visit, new patient (routine) | 1.1% | 563 | $30K |
| 90461 | <1% | 2,697 | $11K | |
| 99381 | <1% | 81 | $6K | |
| 81003 | <1% | 2,561 | $4K | |
| 0071A | <1% | 119 | $4K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 77 | $4K |
| 99050 | <1% | 248 | $3K | |
| 0001A | <1% | 65 | $2K | |
| 99382 | <1% | 24 | $2K | |
| 99000 | <1% | 189 | $2K | |
| 99051 | <1% | 483 | $2K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 42 | $2K |
| 0072A | <1% | 49 | $2K | |
| 0002A | <1% | 33 | $1K | |
| 99384 | <1% | 13 | $1K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 880 | $296.65 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 15 | $145.09 |
| 90686 | <1% | 259 | $63.18 | |
| 90658 | <1% | 650 | $21.45 | |
| 90734 | <1% | 112 | $1.00 | |
| 91300 | 0% | 232 | $0.00 | |
| 90670 | 0% | 1,219 | $0.00 | |
| 90648 | 0% | 679 | $0.00 | |
| 90710 | 0% | 122 | $0.00 | |
| 90633 | 0% | 308 | $0.00 | |
| 90715 | 0% | 68 | $0.00 | |
| 90700 | 0% | 14 | $0.00 | |
| 90707 | 0% | 12 | $0.00 | |
| 90680 | 0% | 638 | $0.00 | |
| 90696 | 0% | 69 | $0.00 | |
| 90723 | 0% | 265 | $0.00 | |
| 91307 | 0% | 188 | $0.00 | |
| 90651 | 0% | 95 | $0.00 | |
| 90620 | 0% | 14 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 14 | $0.00 |
| 90698 | 0% | 14 | $0.00 | |
| 90716 | 0% | 12 | $0.00 | |
| 90697 | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.